Skip to content

Neostigmine

Bloxiverz, Neostigmine Methylsulfate (neostigmine) is a small molecule pharmaceutical. Neostigmine was first approved as Bloxiverz on 2013-05-31. It is used to treat drug-induced abnormalities, myasthenia gravis, urinary bladder diseases, and urinary retention in the USA. It is known to target acetylcholinesterase.
Trade Name Bloxiverz, Neostigmine Methylsulfate
Common Name Neostigmine
Indication drug-induced abnormalities, myasthenia gravis, urinary bladder diseases, urinary retention
Drug Class Cholinesterase inhibitors (physostigmine type)
Neostigmine
Get full access now